Johan Strömqvist
Directeur/Membre du Conseil chez NEWBURY PHARMACEUTICALS AB
Profil
Johan Strömqvist is the founder of Single Technologies AB, where he holds the titles of President & Director since 2014.
He is currently an Independent Director at Newbury Pharmaceuticals AB since 2020.
Dr. Strömqvist has a graduate degree from the University of Stockholm and graduate and doctorate degrees from the Royal Institute of Technology.
Postes actifs de Johan Strömqvist
| Sociétés | Poste | Début |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Directeur/Membre du Conseil | 01/01/2020 |
Single Technologies AB
 Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Fondateur | 01/01/2014 |
Formation de Johan Strömqvist
| University of Stockholm | Graduate Degree |
| Royal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEWBURY PHARMACEUTICALS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Single Technologies AB
Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Commercial Services |
